Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

@article{Lee2014PhaseIT,
  title={Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer},
  author={Keun-Wook Lee and Yu Jung Kim and Kyung Hun Lee and S. -M. Han and Tae-Yong Kim and Do-youn Oh and Seock-Ah Im and T. -Y. Kim and Yung-jue Bang and In Sil Choi and Jee Hyun Kim},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2014},
  volume={74},
  pages={447-455}
}
To investigate the efficacy of gemcitabine plus uracil–tegafur (UFT) combination chemotherapy as a salvage treatment in patients with metastatic colorectal cancer (MCRC). This single-arm phase II study was conducted at three institutions in Korea. Patients with MCRC refractory to fluoropyrimidine, oxaliplatin and irinotecan were enrolled. Gemcitabine 800 mg… CONTINUE READING